PF-05212377
Sponsors
Pfizer
Conditions
Healthy
Phase 1
Scopolamine Challenge Study
CompletedNCT01213355
Start: 2011-04-30End: 2011-08-31Updated: 2018-11-14
This Study Will Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers
CompletedNCT01258751
Start: 2010-12-31End: 2011-05-31Updated: 2011-07-06
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
CompletedNCT02005991
Start: 2013-11-30End: 2014-01-31Updated: 2014-04-16